<DOC>
	<DOCNO>NCT02750605</DOCNO>
	<brief_summary>The purpose trial compare short- medium long-term result treatment PAD ( peripheral arterial disease ) crural artery either drug coat balloon conventional balloon prospective , randomize , single center study Results define : Limb salvage , Event-free survival , Freedom TLR ( target lesion revascularization ) , Primary patency , Clinical success , Serious adverse event , patient followed-up 1 year . Primary endpoint : Primary Patency 12 month Secondary endpoint : Event free survival , Clinical success 6,12 month , Technical success , Serious adverse event , TLR ( clinical driven ) ,</brief_summary>
	<brief_title>DEB ( Drug Eluting Balloon ) Crural Arteries Critical Limb Ischemia</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Critical limb ischemia . Rutherford class 46 Crural disease , long lesion , 2 cm . Life expectancy &gt; 1year &gt; 18 year Pregnancy Patients disapproval Allergy drug contrast</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>